Liraglutide for Low-responders After Bariatric Surgery

NCT04643301 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Cancellation by sponsor

Conditions

Obesity
Obesity, Morbid

Interventions

DRUG: Liraglutide Pen Injector

Sponsor

Zuyderland Medisch Centrum

Collaborators

[object Object]